Dobutamine
- Strength
- 12.5 mg/mL
- Form
- Injection, Solution
- Class
- beta-Adrenergic Agonist
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Dobutamine Hydrochloride
Listed by Baxter Healthcare Corporation
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | beta-Adrenergic Agonist |
| Approval route | NDA — original brand approval |
| NDC code | 0338-1075 |
| FDA application | NDA020255 |
| RxNorm concept | 309985 |
| Package sizes listed | 1 |
| Marketed since | September 1993 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Hospira, Inc.
Not stocked by us — reference only
HF Acquisition Co LLC, DBA HealthFirst
Not stocked by us — reference only
Slate Run Pharmaceuticals
Not stocked by us — reference only
HF Acquisition Co LLC, DBA HealthFirst
Not stocked by us — reference only
HF Acquisition Co LLC, DBA HealthFirst
Not stocked by us — reference only
Dobutamine Hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
Dobutamine Hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.